Neurological examination abnormal
(UMLS:C1112537)
- UMLS ID:
- C1112537
- MeSH ID:
- N/A
Synonym(s)
1.
Neurological examination abnormal
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Gadolinium DTPA | FAERS: 6 | US FAERS | |
| 2 | Dimethyl Fumarate | FAERS: 4 | US FAERS | |
| 3 | Carbamazepine | FAERS: 2 | US FAERS | |
| 4 | Ibuprofen | FAERS: 2 | US FAERS | |
| 5 | Iohexol | FAERS: 2 | US FAERS | |
| 6 | Isotretinoin | FAERS: 2 | US FAERS | |
| 7 | Lamotrigine | FAERS: 2 | US FAERS | |
| 8 | Levofloxacin | FAERS: 2 | US FAERS | |
| 9 | Lidoderm | FAERS: 2 | US FAERS | |
| 10 | Sotalol | FAERS: 2 | US FAERS | |
| 11 | Sotalol | FAERS: 2 | US FAERS | |
| 12 | 2-(Tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydron;chloride | FAERS: 1 | US FAERS | |
| 13 | Afatinib | FAERS: 1 | US FAERS | |
| 14 | Alendronate | FAERS: 1 | US FAERS | |
| 15 | Amiodarone | FAERS: 1 | US FAERS | |
| 16 | Aspirin-oxycodone hydrochloride-oxycodone terephthalate combination | FAERS: 1 | US FAERS | |
| 17 | Bortezomib | FAERS: 1 | US FAERS | |
| 18 | Bosentan | FAERS: 1 | US FAERS | |
| 19 | Dabigatran | FAERS: 1 | US FAERS | |
| 20 | Daptomycin | FAERS: 1 | US FAERS | |
| 21 | Deferasirox | FAERS: 1 | US FAERS | |
| 22 | Desvenlafaxine Succinate | FAERS: 1 | US FAERS | |
| 23 | FS 069 | FAERS: 1 | OFFSIDES US FAERS | |
| 24 | Fingolimod Hydrochloride | FAERS: 1 | US FAERS | |
| 25 | Lidocaine | FAERS: 1 | US FAERS | |
| 26 | Lomustine | FAERS: 1 | US FAERS | |
| 27 | Mefloquine | FAERS: 1 | US FAERS | |
| 28 | Metformin | FAERS: 1 | US FAERS | |
| 29 | Metronidazole | FAERS: 1 | US FAERS | |
| 30 | Mitotane | FAERS: 1 | OFFSIDES US FAERS | |
| 31 | Morphine | FAERS: 1 | US FAERS | |
| 32 | Nitrous Oxide | FAERS: 1 | OFFSIDES US FAERS | |
| 33 | Olanzapine | FAERS: 1 | US FAERS | |
| 34 | Ondansetron | FAERS: 1 | US FAERS | |
| 35 | Ortho Evra | FAERS: 1 | US FAERS | |
| 36 | Oseltamivir | FAERS: 1 | US FAERS | |
| 37 | Oxycodone | FAERS: 1 | US FAERS | |
| 38 | Paroxetine | FAERS: 1 | US FAERS | |
| 39 | Perphenazine | FAERS: 1 | US FAERS | |
| 40 | Pregabalin | FAERS: 1 | US FAERS | |
| 41 | Propofol | FAERS: 1 | US FAERS | |
| 42 | Propylthiouracil | FAERS: 1 | US FAERS | |
| 43 | Rivastigmine | FAERS: 1 | US FAERS | |
| 44 | Rocuronium | FAERS: 1 | US FAERS | |
| 45 | Ruxolitinib phosphate | FAERS: 1 | US FAERS | |
| 46 | Sertraline | FAERS: 1 | US FAERS | |
| 47 | Sildenafil Citrate | FAERS: 1 | US FAERS | |
| 48 | Sorafenib | FAERS: 1 | US FAERS | |
| 49 | Temozolomide | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 50 | Theophylline | FAERS: 1 | US FAERS | |
| 51 | Varenicline | FAERS: 1 | US FAERS | |
| 52 | Venlafaxine Hydrochloride | FAERS: 1 | US FAERS | |
| 53 | estradiol, norethindrone drug combination | FAERS: 1 | US FAERS | |
| 54 | reviparin | FAERS: 1 | US FAERS | |
| 55 | Acarbose | OFFSIDES | ||
| 56 | Benztropine | OFFSIDES | ||
| 57 | Bromocriptine | Canada Vigilance: 1 | Canada Vigilance | |
| 58 | Bupropion | SIDER | ||
| 59 | Caspofungin | OFFSIDES | ||
| 60 | Caspofungin | OFFSIDES | ||
| 61 | Dioctyl Sulfosuccinic Acid | OFFSIDES | ||
| 62 | Eptifibatide | OFFSIDES | ||
| 63 | Fluorescein | OFFSIDES | ||
| 64 | Formoterol Fumarate | OFFSIDES | ||
| 65 | Leflunomide | OFFSIDES | ||
| 66 | Levetiracetam | OFFSIDES | ||
| 67 | Lithium Carbonate | OFFSIDES | ||
| 68 | Mometasone Furoate | OFFSIDES | ||
| 69 | Oxacillin | OFFSIDES | ||
| 70 | Pindolol | OFFSIDES | ||
| 71 | Rosuvastatin Calcium | Canada Vigilance: 1 | Canada Vigilance | |
| 72 | Tetrabenazine | OFFSIDES | ||
| 73 | Thalidomide | OFFSIDES | ||
| 74 | Thiamine | OFFSIDES | ||
| 75 | candesartan cilexetil | OFFSIDES | ||
| 76 | cisatracurium | OFFSIDES | ||
| 77 | loxoprofen | OFFSIDES | ||
| 78 | piretanide | OFFSIDES | ||
| 79 | selenium disulfide | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.